Skip to content
Although illnesses like ulcerative colitis and Crohn’s disease are life-changing, gastrointestinal diseases are largely invisible, with little social recognition or understanding. For underserved communities […]
How COGI fights for policies to support BIPOC IBD patients Read More »
Over 30 representatives from biodefense companies joined the Biotechnology Innovation Organization (BIO) on Capitol Hill in November to meet with bipartisan congressional leaders to
BIO hosts fly-in focused on biodefense, calls for PAHPA reauthorization Read More »
Rep. Buddy Carter (R-GA) held a press conference on Dec. 4 to call on congressional leadership to pass pharmacy benefit manager (PBM) reform before
Rep. Buddy Carter calls for vote on PBM reform before end of year Read More »
Over 75% of clinical trial participants in the U.S. are white. This historical statistic has held true even today, even though the American population
The importance of caregivers in clinical trial diversity Read More »
When Peggy Lillis was put on an antibiotic to treat an abscess after a root canal, her family had no idea of what was
4 things to know during C. diff Awareness Month Read More »
It is open enrollment season for Medicare Part D, and the patient-led advocacy coalition MAPRx is helping patients get the coverage they need. Open
MAPRx is helping patients navigate open enrollment Read More »
The U.S. Food and Drug Administration (FDA) announced the creation of its Rare Disease Innovation Hub in July 2024. With the goal of engaging
BIO makes recommendation for new FDA Rare Disease Innovation Hub Read More »
Patient advocates from across the country gathered in Washington, D.C., on October 23-24 for the BIO Patient and Health Advocacy Summit (PHAS). This event
PHAS 2024: Patient advocates unite to share stories and address barriers to treatment Read More »
“All of us have been paying attention and seeing the ‘AI high’ for the last several years,” said Ruchita Sinha, MBA, General Partner at
BIF 2024: AI experts discuss use cases, benefits, ROI Read More »
The Inflation Reduction Act (IRA) has been top of mind for many in the biotech industry. The first round of price negotiations and the
BIF 2024: ‘The IRA really disrupted how we think’ Read More »
